Report Detail
Global Oncolytic Virus Therapy Market Size, Status and Forecast 2019-2025
- RnM3362248 |
- 29 April, 2019 |
- Global |
- 96 Pages |
- QYResearch |
- Other
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The application of oncolytic virus therapy includes melanoma, prostate cancer, breast cancer, ovarian cancer and others, and the proportion of R&D Investment for melanoma in 2017 is about 34%.
Market competition is intense. Amgen, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry.
In 2018, the global Oncolytic Virus Therapy market size was 2 million US$ and it is expected to reach 14 million US$ by the end of 2025, with a CAGR of 24.9% during 2019-2025.
This report focuses on the global Oncolytic Virus Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncolytic Virus Therapy development in United States, Europe and China.
The key players covered in this study
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Market segment by Type, the product can be split into
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Market segment by Application, split into
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oncolytic Virus Therapy status, future forecast, growth opportunity, key market and key players.
To present the Oncolytic Virus Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncolytic Virus Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type (2014-2025)
- 1.4.2 HSV-based Oncolytic Viruses
- 1.4.3 Adenoviruses-based Oncolytic Viruses
- 1.4.4 Vaccinia Virus-based Oncolytic Viruses
- 1.4.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
- 1.4.6 Newcastle Disease Virus-based Oncolytic Viruses
- 1.5 Market by Application
- 1.5.1 Global Oncolytic Virus Therapy Market Share by Application (2014-2025)
- 1.5.2 Melanoma
- 1.5.3 Prostate Cancer
- 1.5.4 Breast Cancer
- 1.5.5 Ovarian Cancer
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Oncolytic Virus Therapy Market Size
- 2.2 Oncolytic Virus Therapy Growth Trends by Regions
- 2.2.1 Oncolytic Virus Therapy Market Size by Regions (2014-2025)
- 2.2.2 Oncolytic Virus Therapy Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Oncolytic Virus Therapy Market Size by Manufacturers
- 3.1.1 Global Oncolytic Virus Therapy Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
- 3.2 Oncolytic Virus Therapy Key Players Head office and Area Served
- 3.3 Key Players Oncolytic Virus Therapy Product/Solution/Service
- 3.4 Date of Enter into Oncolytic Virus Therapy Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Oncolytic Virus Therapy Market Size by Type (2014-2019)
- 4.2 Global Oncolytic Virus Therapy Market Size by Application (2014-2019)
5 United States
- 5.1 United States Oncolytic Virus Therapy Market Size (2014-2019)
- 5.2 Oncolytic Virus Therapy Key Players in United States
- 5.3 United States Oncolytic Virus Therapy Market Size by Type
- 5.4 United States Oncolytic Virus Therapy Market Size by Application
6 Europe
- 6.1 Europe Oncolytic Virus Therapy Market Size (2014-2019)
- 6.2 Oncolytic Virus Therapy Key Players in Europe
- 6.3 Europe Oncolytic Virus Therapy Market Size by Type
- 6.4 Europe Oncolytic Virus Therapy Market Size by Application
7 China
- 7.1 China Oncolytic Virus Therapy Market Size (2014-2019)
- 7.2 Oncolytic Virus Therapy Key Players in China
- 7.3 China Oncolytic Virus Therapy Market Size by Type
- 7.4 China Oncolytic Virus Therapy Market Size by Application
8 Japan
- 8.1 Japan Oncolytic Virus Therapy Market Size (2014-2019)
- 8.2 Oncolytic Virus Therapy Key Players in Japan
- 8.3 Japan Oncolytic Virus Therapy Market Size by Type
- 8.4 Japan Oncolytic Virus Therapy Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Oncolytic Virus Therapy Market Size (2014-2019)
- 9.2 Oncolytic Virus Therapy Key Players in Southeast Asia
- 9.3 Southeast Asia Oncolytic Virus Therapy Market Size by Type
- 9.4 Southeast Asia Oncolytic Virus Therapy Market Size by Application
10 India
- 10.1 India Oncolytic Virus Therapy Market Size (2014-2019)
- 10.2 Oncolytic Virus Therapy Key Players in India
- 10.3 India Oncolytic Virus Therapy Market Size by Type
- 10.4 India Oncolytic Virus Therapy Market Size by Application
11 Central & South America
- 11.1 Central & South America Oncolytic Virus Therapy Market Size (2014-2019)
- 11.2 Oncolytic Virus Therapy Key Players in Central & South America
- 11.3 Central & South America Oncolytic Virus Therapy Market Size by Type
- 11.4 Central & South America Oncolytic Virus Therapy Market Size by Application
12 International Players Profiles
- 12.1 Amgen
- 12.1.1 Amgen Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Oncolytic Virus Therapy Introduction
- 12.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.1.5 Amgen Recent Development
- 12.2 Oncolytics Biotech
- 12.2.1 Oncolytics Biotech Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Oncolytic Virus Therapy Introduction
- 12.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.2.5 Oncolytics Biotech Recent Development
- 12.3 Viralytics
- 12.3.1 Viralytics Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Oncolytic Virus Therapy Introduction
- 12.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.3.5 Viralytics Recent Development
- 12.4 Transgene SA
- 12.4.1 Transgene SA Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Oncolytic Virus Therapy Introduction
- 12.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.4.5 Transgene SA Recent Development
- 12.5 Oncolys BioPharma
- 12.5.1 Oncolys BioPharma Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Oncolytic Virus Therapy Introduction
- 12.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.5.5 Oncolys BioPharma Recent Development
- 12.6 Targovax
- 12.6.1 Targovax Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Oncolytic Virus Therapy Introduction
- 12.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.6.5 Targovax Recent Development
- 12.7 PsiOxus Therapeutics
- 12.7.1 PsiOxus Therapeutics Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Oncolytic Virus Therapy Introduction
- 12.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.7.5 PsiOxus Therapeutics Recent Development
- 12.8 SillaJen Biotherapeutics
- 12.8.1 SillaJen Biotherapeutics Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Oncolytic Virus Therapy Introduction
- 12.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.8.5 SillaJen Biotherapeutics Recent Development
- 12.9 Sorrento Therapeutics
- 12.9.1 Sorrento Therapeutics Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Oncolytic Virus Therapy Introduction
- 12.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.9.5 Sorrento Therapeutics Recent Development
- 12.10 Lokon Pharma
- 12.10.1 Lokon Pharma Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Oncolytic Virus Therapy Introduction
- 12.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2014-2019)
- 12.10.5 Lokon Pharma Recent Development
- 12.11 Genelux Corporation
- 12.12 Vyriad
- 12.13 TILT Biotherapeutics
- 12.14 Cold Genesys
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Oncolytic Virus Therapy . Industry analysis & Market Report on Oncolytic Virus Therapy is a syndicated market report, published as Global Oncolytic Virus Therapy Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Oncolytic Virus Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
